Antibiotic business model needs overhaul

Current model leads to antibiotic overconsumption and provides insufficient rewards to drive innovation, say top researchers Academics from the Boston University School of Law and London School of Economics, among others, have written an essay in PLoS Medicine pointing out the ineffectiveness of the model. Health care workers are increasingly cautious about prescribing new antibiotics